SorafenibNeutropenia and off label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1927卷 / 1期

关键词：

D O I：

10.1007/s40278-022-25218-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：482 / 482

相关论文

共 50 条

[21] AntineoplasticsLack of efficacy and off label use: case report
Reactions Weekly, 2021, 1853 (1) : 51 - 51
[22] Multiple drugsInfections and off label use: case report
Reactions Weekly, 2021, 1884 (1) : 293 - 293
[23] Brentuximab vedotinNeutropenia and off label use: case report
Reactions Weekly, 2021, 1847 (1) : 107 - 107
[24] AntineoplasticsLack of efficacy and off label use: case report
Reactions Weekly, 2020, 1823 (1) : 56 - 56
[25] VenetoclaxMyelosuppression following off label use: case report
Reactions Weekly, 2021, 1842 (1) : 361 - 361
[26] NivolumabInterstitial pneumonia and off label use: case report
Reactions Weekly, 2020, 1826 (1) : 254 - 254
[27] DexmedetomidineBradycardia following off label use: case report
Reactions Weekly, 2022, 1935 (1) : 182 - 182
[28] CinacalcetHyperphosphataemia following off label use: case report
Reactions Weekly, 2019, 1769 (1) : 121 - 121
[29] MethylprednisolonePulmonary mucormycosis and off label use: case report
Reactions Weekly, 2022, 1913 (1) : 287 - 287
[30] HydroxychloroquineRash following off label use: case report
Reactions Weekly, 2020, 1822 (1) : 154 - 154

← 1 2 3 4 5 →